iBio, Inc. ( IBIO) - Stock Earnings
IBIO Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 11, 2026, midnight | — / — | — | — / — | — |
IBIO Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -9.0 million USD | — USD |
| 2026Q1 | -7.7 million USD | — USD |
| 2026Q2 | -10.6 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
IBIO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | -24.9 million USD | 225000 USD |
| 2025 | -18.4 million USD | 400000 USD |
| 2026 | -33.0 million USD | 100000 USD |
| 2026 Est. | — | — |
IBIO
Price: $0.77
52 week price:
Earnings Per Share: -0.32 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.7 million
Market Capitalization: 72.0 million